Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Insight Public Affairs

We are an award winning 15-strong team of consultants able to offer extensive experience in politics, government, media and stakeholder engagement, across a breadth of policy areas including telecoms, technology, gambling, life sciences, financial services, housing, infrastructure, copyright, employment, media and advertising, food and drink, social care, retail, and education. As an independent agency we go that extra mile to deliver results-focussed communications strategies and programmes that fulfil our clients’ commercial imperatives. Working tirelessly to meet our clients’ goals, we are a team who understand client challenges, develop bespoke strategies and programmes, and meet these strategic objectives.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Insight Public Affairs
52 Grosvenor Gardens, London, SW1W 0AU, United Kingdom
+44 (0)20 7824 1865
Contact Insight Public Affairs
Website

 Latest Content from PMHub 

Engage Internal Teams Virtually – Engaging Your Advisors Creatively

Videos and Podcasts | August 7, 2025 | Impetus Digital

Boost internal effectiveness! Learn a creative way to use virtual advisory boards to facilitate best practice-sharing with sales representatives and knowledge-sharing with MSLs. This is the key to aligning your...

The Mission to Humanize Healthcare

Press Releases | August 7, 2025 | Medscape Education

Medical and scientific innovation are in a fast lane closely pursued by digital advances but their dynamism can mute a vital element of progressive healthcare – patient integration.

Implementation of Cost-Effectiveness Analysis in Japan’s Health Technology Assessment Process

White Papers and Resources | August 6, 2025 | Petauri Evidence

Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health technology assessment (HTA)...

Designing with patients in mind: How to build more inclusive clinical trials

Press Releases | August 4, 2025 | Cuttsy + Cuttsy

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

White Papers and Resources | August 1, 2025 | Innovative Trials

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

White Papers and Resources | August 1, 2025 | Innovative Trials

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

Three Key Trends Shaping the Future of Clinical Trials

White Papers and Resources | August 1, 2025 | Innovative Trials

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

Advertising For Women’s Health: Breaking Taboos and Driving Change

White Papers and Resources | July 30, 2025 | 11 London

Our strategist Stephanie Goley, MSc, PhD takes a fascinating look at how advertising is breaking down stigmas around areas of women's health such as menstruation and menopause - and helping...

Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

Press Releases | July 30, 2025 | Genesis Research Group

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

Digital Transformation in the NHS’s 10-Year Plan: Techno-Optimism and the Limits of Efficiency

White Papers and Resources | July 29, 2025 | Petauri Evidence

Here, Evelyne Priestman (Senior Consultant – HEOR) and Mary Baker (Senior Medical Writer) at Petauri Evidence explore the National Health Service (NHS) in England’s newly unveiled 10-year plan through the...